(Q40589131)

English

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A

scientific article published on July 10, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A (English)

reason for preferred rank

most precise value

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740924

1 January 2024

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Jan-Erik Frodin

6

object named as

Jan-Erik Frödin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740924

1 January 2024

author name string

Maria Liljefors

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bo Nilsson

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Anna-Lena Hjelm Skog

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Peter Ragnhammar

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Håkan Mellstedt

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

10 July 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12740924

1 January 2024

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.11139

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.11139

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

717-723

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Biology of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: apoptosis induction and cytotoxic mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

NK and NK/T cells in human senescence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Age-dependent decline of natural killer and antibody-dependent cell mediated cytotoxicity activity of human lymphocytes is connected with decrease of their acid phosphatase activity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11139

21 January 2018

Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma

1

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells

4

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy

10

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Prognostic significance of natural killer cell activity in patients with laryngeal carcinoma

11

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Preoperative natural killer cell activity: correlation with distant metastases in curatively research colorectal carcinomas

12

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer

13

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Cellular immunologic parameters related to age, gender, and stage in lung cancer patients

14

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells

20

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer

25

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Lymphokine activated killer (LAK) cells in antibody dependent cellular cytotoxicity (ADCC) using MAb 17-1A: a combination of potential usefulness in tumor therapy

27

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced

28

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells

29

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Increased killer cell activity in aged humans

33

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Natural killer cells and tumor therapy

34

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Escape from host-antitumor immunity.

35

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Natural killer activity in patients with breast cancer

36

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Natural killing activity is associated with progression of gastric cancer

37

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

A new prognostic classification of rectal cancer

41

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment

45

1 reference

10.1002/IJC.11139

https://api.crossref.org/works/10.1002/IJC.11139

1 January 2024

Identifiers

10.1002/IJC.11139

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40589131&oldid=2042184253"